A Sequential Window of Opportunity Trial of Anti-PD-L1/TGF-β trap (M7824) Alone and in Combination with TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma not Associated with Human Papillomavirus Infection

Platforms
dbGaP
View in dbGaP

Consent Codes

DS-HNSC-PUB

Focus / Diseases

Squamous Cell Carcinoma of Head and Neck

Study Design

Clinical Trial

Data Types

OTHER, RNA-Seq, WXS

Subjects

14